CTRE vs LINE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CareTrust REIT (CTRE) presents a dichotomy between strong balance sheet health and fundamental overvaluation. While the Piotroski F-Score of 4/9 indicates stable financial health and the Debt/Equity ratio (0.72) is significantly superior to the sector average (2.76), the stock trades at a substantial premium to its Graham Number ($25.3) and Intrinsic Value ($22.77). Recent performance is marred by a streak of four consecutive earnings misses with an average surprise of -11.89%, offsetting the bullish analyst consensus. The outlook remains neutral as the market price reflects growth expectations that are not currently supported by recent earnings delivery.
Lineage, Inc. exhibits significant fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. While the stock trades at a slight discount to book value (P/B 0.94) and has recently outperformed low earnings expectations, these are overshadowed by a 0/100 technical trend and stagnant revenue growth (-0.20% YoY). Liquidity is a concern with a current ratio of 0.80, and the negative forward P/E suggests continued profitability struggles. The high dividend yield of 6.20% appears unsustainable given the negative profit margins.
Compare Another Pair
Related Comparisons
CTRE vs LINE: Head-to-Head Comparison
This page compares CareTrust REIT, Inc. (CTRE) and Lineage, Inc. (LINE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.